Health ProductsType I recall

AMITRIPTYLINE 10 & 50mg: NDMA and NNORT impurity

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: AMITRIPTYLINE 10 & 50mg
Issue: Health products - Contamination
What to do: Consult your health care professional if you have any health concerns.
Distribution: Quebec
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandLotProduct NameMarket AuthorizationDosage FormStrength
AMITRIPTYLINE632627, 633441, 638164AMITRIPTYLINE 10mgDIN 00370991TabletAmitriptyline Hydrochloride 10mg
AMITRIPTYLINE633436AMITRIPTYLINE 50 mgDIN 00456349TabletAmitriptyline Hydrochloride 50mg

Issue

Affected lot exceed the acceptable cumulative intake limit for N-nitrosodimethylamine (NDMA) and N-nitroso-nortriptyline (NNORT).

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime